Drug Interactions between hydrochlorothiazide / losartan and paroxetine
This report displays the potential drug interactions for the following 2 drugs:
- hydrochlorothiazide/losartan
- paroxetine
Interactions between your drugs
hydroCHLOROthiazide PARoxetine
Applies to: hydrochlorothiazide / losartan and paroxetine
MONITOR: Coadministration with diuretics may potentiate the risk of hyponatremia associated with the use of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). The mechanism by which SSRIs and SNRIs produce hyponatremia has not been clearly established. In many cases, the hyponatremia appears to be secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Cases with serum sodium lower than 110 mmol/L have been reported. These events are generally reversible following discontinuation of therapy and/or medical intervention. Elderly patients and patients taking diuretics or who are otherwise volume-depleted may be at greater risk of developing hyponatremia with SSRIs and SNRIs.
MONITOR: Antihypertensive agents such as diuretics may potentiate the orthostatic effect that is occasionally observed upon the initiation of SSRI or SNRI therapy. Syncope and orthostatic hypotension tend to occur within the first week of SNRI/SSRI therapy but can occur at any time during treatment, particularly after a dosage increase. The use of SSRIs or SNRIs may also cause sustained increases in blood pressure and heart rate, which may antagonize the therapeutic effects of antihypertensive medications. Cases of elevated blood pressure requiring immediate treatment have been reported in postmarketing experience.
MANAGEMENT: Caution is recommended if SSRIs or SNRIs are prescribed in combination with diuretics, particularly in the elderly. Patients should be advised to seek medical attention if they experience potential signs and symptoms of hyponatremia such as nausea, vomiting, headache, malaise, lethargy, irritability, difficulty concentrating, memory impairment, confusion, weakness, muscle spasm, and unsteadiness (which may lead to falls). More severe and/or acute cases may include hallucination, syncope, seizure, coma, respiratory arrest, and death. Discontinuation of SSRI/SNRI therapy should be considered in patients who develop symptomatic hyponatremia, and appropriate medical intervention instituted as necessary. Patients should also have their blood pressure and pulse monitored before and during SSRI/SNRI therapy, especially during the first few weeks and following a dosage increase. Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their doctor if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia. Patients should also avoid driving or operating hazardous machinery until they know how the medications affect them. Dose reduction or drug discontinuation should be considered in patients who experience a sustained increase in blood pressure or pulse rate during SSRI or SNRI therapy.
References (54)
- Hwang AS, Magraw RM (1989) "Syndrome of inappropriate secretion of antidiuretic hormone due to fluoxetine." Am J Psychiatry, 146, p. 399
- Vishwanath BM, Navalgund AA, Cusano W, Navalgund KA (1991) "Fluoxetine as a cause of SIADH." Am J Psychiatry, 148, p. 542-3
- Staab JP, Yerkes SA, Cheney EM, Clayton AH (1990) "Transient SIADH associated with fluoxetine." Am J Psychiatry, 147, p. 1569-70
- Cohen BJ, Mahelsky M, Adler L (1990) "More cases of SIADH with fluoxetine." Am J Psychiatry, 147, p. 948-9
- Spier SA, Frontera MA (1991) "Unexpected deaths in depressed medical inpatients treated with fluoxetine." J Clin Psychiatry, 52, p. 377-82
- Feder R (1991) "Bradycardia and syncope induced by fluoxetine." J Clin Psychiatry, 52, p. 139
- Ellison JM, Milofsky JE, Ely E (1990) "Fluoxetine-induced bradycardia and syncope in two patients." J Clin Psychiatry, 51, p. 385-6
- Kazal LA, Jr Hall DL, Miller LG, Noel ML (1993) "Fluoxetine-induced SIADH: a geriatric occurrence?" J Fam Pract, 36, p. 341-3
- Crews JR, Potts NL, Schreiber J, Lipper S (1993) "Hyponatremia in a patient treated with sertraline." Am J Psychiatry, 150, p. 1564
- Blacksten JV, Birt JA (1993) "Syndrome of inappropriate secretion of antidiuretic hormone secondary to fluoxetine." Ann Pharmacother, 27, p. 723-4
- (2001) "Product Information. Zoloft (sertraline)." Roerig Division
- (2001) "Product Information. Prozac (fluoxetine)." Dista Products Company
- (2001) "Product Information. Effexor (venlafaxine)." Wyeth-Ayerst Laboratories
- Chua TP, Vong SK (1993) "Hyponatraemia associated with paroxetine." BMJ, 306, p. 143
- Goddard C, Paton C (1992) "Hyponatraemia associated with paroxetine." BMJ, 305, p. 1332
- (2001) "Product Information. Paxil (paroxetine)." GlaxoSmithKline
- Doshi D, Borison R (1994) "Association of transient SIADH with sertraline." Am J Psychiatry, 151, p. 779-80
- Baliga RR, McHardy KC (1993) "Syndrome of inappropriate antidiuretic hormone secretion due to fluvoxamine therapy [published erratum appears in Br J Clin Pract 1993 May-Jun;47(3):119]." Br J Clin Pract, 47, p. 62-3
- (2001) "Product Information. Luvox (fluvoxamine)." Solvay Pharmaceuticals Inc
- Llorente MD, Gorelick M, Silverman MA (1994) "Sertraline as the cause of inappropriate antidiuretic hormone secretion." J Clin Psychiatry, 55, p. 543-4
- Thornton SL, Resch DS (1995) "SIADH associated with sertraline therapy." Am J Psychiatry, 152, p. 809
- Jackson C, Carson W, Markowitz J, Mintzer J (1995) "SIADH associated with fluoxetine and sertraline therapy." Am J Psychiatry, 152, p. 809-10
- Ayonrinde OT, Reutens SG, Sanfilippo FM (1995) "Paroxetine-induced SIADH." Med J Aust, 163, p. 390
- Kessler J, Samuels SC (1996) "Sertraline and hyponatremia." N Engl J Med, 335, p. 524
- Bradley ME, Foote EF, Lee EN, Merkle L (1996) "Sertraline-associated syndrome of inappropriate antidiuretic hormone: case report and review of the literature." Pharmacotherapy, 16, p. 680-3
- (1996) "Selective serotonin reuptake inhibitors and SIADH." Med J Aust, 164, p. 562
- Robinson D, Brooks J, Mahler E, Sheikh JI (1996) "SIADH--compulsive drinking or SSRI influence?" Ann Pharmacother, 30, p. 885
- Schattner A, Skurnik Y (1996) "Fluoxetine-induced SIADH." J Am Geriatr Soc, 44, p. 1413
- van Campen JP, Voets AJ (1996) "SIADH caused by paroxetine." Ann Pharmacother, 30, p. 1499
- Woo MH, Smythe MA (1997) "Association of SIADH with selective serotonin reuptake inhibitors." Ann Pharmacother, 31, p. 108-10
- Spigset O, hedenmalm K (1997) "Hyponatremia in relation to treatment with antidepressants: a survey of reports in the World Health Organization data base for spontaneous reporting of adverse drug reactions." Pharmacotherapy, 17, p. 348-52
- Bouman WP, Johnson H, TrescoliSerrano C, Jones RG (1997) "Recurrent hyponatremia associated with sertraline and lofepramine." Am J Psychiatry, 154, p. 580
- Girault C, Richard JC, Chevron V, Goulle JP, Droy JM, Bonmarchand G, Leroy J (1997) "Syndrome of inappropriate secretion of antidiuretic hormone in two elderly women with elevated serum fluoxetine." J Toxicol Clin Toxicol, 35, p. 93-5
- Ayonrinde OT, Sanfilippo FM (1997) "SSRI antidepressants and SIADH." Aust N Z J Psychiatry, 31, p. 306-7
- (2001) "Product Information. Celexa (citalopram)." Forest Pharmaceuticals
- Madhusoodanan S, Brenner R, Brafman I, Bogunovic O (1999) "Hyponatremia associated with paroxetine use." South Med J, 92, p. 843
- Odeh M, Seligmann H, Oliven A (1999) "Severe life-threatening hyponatremia during paroxetine therapy." J Clin Pharmacol, 39, p. 1290-1
- Odeh M, Beny A, Oliven A (2001) "Severe symptomatic hyponatremia during citalopram therapy." Am J Med Sci, 321, p. 159-60
- Rodriguez de la Torre B, Dreher J, Malevany I, et al. (2001) "Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients." Ther Drug Monit, 23, p. 435-40
- (2002) "Product Information. Lexapro (escitalopram)." Forest Pharmaceuticals
- Barclay TS, Lee AJ (2002) "Citalopram-associated SIADH." Ann Pharmacother, 36, p. 1558-63
- Rosner MH (2004) "Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors." Am J Med Sci, 327, p. 109-11
- (2004) "Product Information. Cymbalta (duloxetine)." Lilly, Eli and Company
- Jacob S, Spinler SA (2006) "Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults." Ann Pharmacother, 40, p. 1618-22
- Covyeou JA, Jackson CW (2007) "Hyponatremia associated with escitalopram." N Engl J Med, 356, p. 94-5
- (2008) "Product Information. Pristiq (desvenlafaxine)." Wyeth Laboratories
- Fitzgerald MA (2008) "Hyponatremia associated with SSRI use in a 65-year-old woman." Nurse Pract, 33, p. 11-2
- Esposito P, Rampino T, Gregorini M, et al. (2008) "Severe symptomatic hyponatremia during sibutramine therapy: a case report." Am J Kidney Dis, 52, p. 137-9
- (2009) "Product Information. Savella (milnacipran)." Forest Pharmaceuticals
- Pacher P, Kecskemeti V (2004) "Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?" Curr Pharm Des, 10, p. 2463-75
- Andrews C, Pinner G (1998) "Postural hypotension induced by paroxetine." BMJ, 316, p. 595
- (2011) "Product Information. Viibryd (vilazodone)." Trovis Pharmaceuticals LLC
- (2013) "Product Information. Fetzima (levomilnacipran)." Forest Pharmaceuticals
- (2013) "Product Information. Brintellix (vortioxetine)." Takeda Pharmaceuticals America
Drug and food interactions
PARoxetine food
Applies to: paroxetine
GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of CNS-active agents. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.
MANAGEMENT: Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol. Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.
References (4)
- Warrington SJ, Ankier SI, Turner P (1986) "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology, 15, p. 31-7
- Gilman AG, eds., Nies AS, Rall TW, Taylor P (1990) "Goodman and Gilman's the Pharmacological Basis of Therapeutics." New York, NY: Pergamon Press Inc.
- (2012) "Product Information. Fycompa (perampanel)." Eisai Inc
- (2015) "Product Information. Rexulti (brexpiprazole)." Otsuka American Pharmaceuticals Inc
losartan food
Applies to: hydrochlorothiazide / losartan
GENERALLY AVOID: Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs). ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion. Patients with diabetes, heart failure, dehydration, or renal insufficiency have a greater risk of developing hyperkalemia.
MANAGEMENT: Patients should receive dietary counseling and be advised to not use potassium-containing salt substitutes or over-the-counter potassium supplements without consulting their physician. If salt substitutes are used concurrently, regular monitoring of serum potassium levels is recommended. Patients should also be advised to seek medical attention if they experience symptoms of hyperkalemia such as weakness, irregular heartbeat, confusion, tingling of the extremities, or feelings of heaviness in the legs.
MONITOR: Grapefruit juice may modestly decrease and delay the conversion of losartan to its active metabolite, E3174. The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits. The clinical significance is unknown. Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.
MANAGEMENT: Patients who regularly consume grapefruits and grapefruit juice should be monitored for altered efficacy of losartan. Grapefruits and grapefruit juice should be avoided if an interaction is suspected. Orange juice is not expected to interact.
References (3)
- (2001) "Product Information. Cozaar (losartan)." Merck & Co., Inc
- Zaidenstein R, Soback S, Gips M, Avni B, Dishi V, Weissgarten Y, Golik A, Scapa E (2001) "Effect of grapefruit juice on the pharmacokinetics of losartan and its active metabolite E3174 in healthy volunteers." Ther Drug Monit, 23, p. 369-73
- Ray K, Dorman S, Watson R (1999) "Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction." J Hum Hypertens, 13, p. 717-20
hydroCHLOROthiazide food
Applies to: hydrochlorothiazide / losartan
MONITOR: Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation. Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.
MANAGEMENT: Caution and close monitoring for development of hypotension is advised during coadministration of these agents. Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs. Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia. Patients should also avoid driving or operating hazardous machinery until they know how the medications affect them.
References (10)
- Sternbach H (1991) "Fluoxetine-associated potentiation of calcium-channel blockers." J Clin Psychopharmacol, 11, p. 390-1
- Shook TL, Kirshenbaum JM, Hundley RF, Shorey JM, Lamas GA (1984) "Ethanol intoxication complicating intravenous nitroglycerin therapy." Ann Intern Med, 101, p. 498-9
- Feder R (1991) "Bradycardia and syncope induced by fluoxetine." J Clin Psychiatry, 52, p. 139
- Ellison JM, Milofsky JE, Ely E (1990) "Fluoxetine-induced bradycardia and syncope in two patients." J Clin Psychiatry, 51, p. 385-6
- Rodriguez de la Torre B, Dreher J, Malevany I, et al. (2001) "Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients." Ther Drug Monit, 23, p. 435-40
- Cerner Multum, Inc. "Australian Product Information."
- Pacher P, Kecskemeti V (2004) "Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?" Curr Pharm Des, 10, p. 2463-75
- Andrews C, Pinner G (1998) "Postural hypotension induced by paroxetine." BMJ, 316, p. 595
- (2023) "Product Information. Buprenorphine (buprenorphine)." G.L. Pharma UK Ltd
- (2023) "Product Information. Temgesic (buprenorphine)." Reckitt Benckiser Pty Ltd
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.